PhaseRx Statistics
Total Valuation
PhaseRx has a market cap or net worth of 1,171.
| Market Cap | 1,171 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
PhaseRx has 11.71 million shares outstanding.
| Current Share Class | 11.71M |
| Shares Outstanding | 11.71M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14
| Current Ratio | 2.14 |
| Quick Ratio | 1.93 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.42 |
| Interest Coverage | -13.83 |
Financial Efficiency
Return on equity (ROE) is -228.17% and return on invested capital (ROIC) is -70.16%.
| Return on Equity (ROE) | -228.17% |
| Return on Assets (ROA) | -64.20% |
| Return on Invested Capital (ROIC) | -70.16% |
| Return on Capital Employed (ROCE) | -393.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.39M |
| Employee Count | 10 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -50.00% in the last 52 weeks. The beta is 1.52, so PhaseRx's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -50.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 43.11 |
| Average Volume (20 Days) | 3,041 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.04M |
| Pretax Income | -13.89M |
| Net Income | -13.89M |
| EBITDA | -12.96M |
| EBIT | -13.04M |
| Earnings Per Share (EPS) | -1.19 |
Balance Sheet
The company has 5.26 million in cash and 5.44 million in debt, giving a net cash position of -184,000 or -0.02 per share.
| Cash & Cash Equivalents | 5.26M |
| Total Debt | 5.44M |
| Net Cash | -184,000 |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -301,000 |
| Book Value Per Share | -0.03 |
| Working Capital | 3.10M |
Cash Flow
In the last 12 months, operating cash flow was -12.82 million and capital expenditures -14,000, giving a free cash flow of -12.84 million.
| Operating Cash Flow | -12.82M |
| Capital Expenditures | -14,000 |
| Free Cash Flow | -12.84M |
| FCF Per Share | -1.10 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PhaseRx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -147.73% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,186,251.07% |
| FCF Yield | -1,096,071.73% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |